119 related articles for article (PubMed ID: 26299617)
21. Klotho expression in cervical cancer: differential expression in adenocarcinoma and squamous cell carcinoma.
Aviel-Ronen S; Rubinek T; Zadok O; Vituri A; Avivi C; Wolf I; Barshack I
J Clin Pathol; 2016 Jan; 69(1):53-7. PubMed ID: 26209729
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
[TBL] [Abstract][Full Text] [Related]
23. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of cellular immune response in cervical cancer.
Ancuta E; Ancuţa C; Zugun-Eloae F; Iordache C; Chirieac R; Carasevici E
Rom J Morphol Embryol; 2009; 50(4):651-5. PubMed ID: 19942961
[TBL] [Abstract][Full Text] [Related]
25. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
26. The tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome.
Gorter A; Prins F; van Diepen M; Punt S; van der Burg SH
J Transl Med; 2015 Sep; 13():295. PubMed ID: 26357849
[TBL] [Abstract][Full Text] [Related]
27. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
28. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease.
Walentowicz-Sadlecka M; Koper A; Krystyna G; Koper K; Basta P; Mach P; Skret-Magierlo J; Dutsch-Wicherek M; Sikora J; Grabiec M; Kazmierczak W; Wicherek L
Am J Reprod Immunol; 2013 Sep; 70(3):253-61. PubMed ID: 23590599
[TBL] [Abstract][Full Text] [Related]
29. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
31. Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.
Yeasmin S; Nakayama K; Ishibashi M; Katagiri A; Iida K; Purwana IN; Nakayama N; Miyazaki K
Clin Cancer Res; 2008 Mar; 14(6):1686-91. PubMed ID: 18347169
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
33. Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer.
Liao CJ; Wu TI; Huang YH; Chang TC; Wang CS; Tsai MM; Lai CH; Liang Y; Jung SM; Lin KH
Cancer Sci; 2011 Dec; 102(12):2255-63. PubMed ID: 21917082
[TBL] [Abstract][Full Text] [Related]
34. Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.
Cao L; Huang Q; He J; Lu J; Xiong Y
Cell Tissue Res; 2013 May; 352(2):361-9. PubMed ID: 23420450
[TBL] [Abstract][Full Text] [Related]
35. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
[TBL] [Abstract][Full Text] [Related]
36. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
37. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer SW; Piñón JD; Brachtl G; Haginger L; Wang W; Jöhrer K; Tinhofer I; Hartmann TN; Greil R
Cancer Res; 2010 Sep; 70(18):7336-44. PubMed ID: 20823161
[TBL] [Abstract][Full Text] [Related]
38. Stomatin-like protein 2 expression is associated with clinical survival in patients with cervical cancer.
Xiao B; Xie Z; Guo L; Wu J; Zhang H
Int J Clin Exp Pathol; 2015; 8(2):1804-9. PubMed ID: 25973071
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
Sato M; Kawana K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Adachi K; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Oncol Rep; 2016 Jan; 35(1):391-7. PubMed ID: 26530461
[TBL] [Abstract][Full Text] [Related]
40. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
Yokohama A; Saitoh A; Nakahashi H; Mitsui T; Koiso H; Kim Y; Uchiumi H; Saitoh T; Handa H; Jimbo T; Murayama K; Sakura T; Murakami H; Karasawa M; Nojima Y; Tsukamoto N
Int J Hematol; 2012 Jan; 95(1):77-85. PubMed ID: 22189846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]